Publications by authors named "Tim M Lavin"
Article Synopsis
- The study focuses on switching patients with inflammatory neuropathies from intravenous immunoglobulin (IVIg) to subcutaneous immunoglobulin (SCIg), assessing the effectiveness of dosing strategies.*
-
- A total of 44 out of 56 patients maintained their SCIg treatment for an average of 3.3 years with stable clinical outcomes; however, some needed dose adjustments over time for better management.*
-
- The findings suggest that adjusting doses based on patient response is a viable method for maintaining effective SCIg therapy, although some patients reverted back to IVIg due to relapses or personal choice.*
Article Synopsis
- This study investigated the potential link between COVID-19 and Guillain-Barré syndrome (GBS) by analyzing GBS cases in the UK before and during the COVID-19 pandemic.
- The researchers found that GBS incidence decreased during the pandemic and did not show a correlation with COVID-19 infection rates across different regions.
- Although some GBS cases were associated with COVID-19, there were no significant differences in clinical features between COVID-19 positive and negative cases, suggesting no strong evidence linking the virus as a cause of GBS.
